BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18274641)

  • 1. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.
    Wang W; Liu F; Chen N
    Mediators Inflamm; 2007; 2007():62641. PubMed ID: 18274641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
    Wang WM; Liu F; Chen N
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
    Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
    J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism underlying the inhibitory effects of peroxisome proliferator-activated receptor γ agonists on transforming growth factor β1 in adult skin fibroblasts].
    Yang CZ; Zhang HT; Wang GS; Zhou HQ; Ma C; Hu DH
    Zhonghua Shao Shang Za Zhi; 2010 Dec; 26(6):448-51. PubMed ID: 21223655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition.
    Zhou X; Zhang J; Xu C; Wang W
    J Pharmacol Sci; 2014; 126(4):344-50. PubMed ID: 25452269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation.
    Meng Z; Yu XH; Chen J; Li L; Li S
    Acta Pharmacol Sin; 2014 Oct; 35(10):1247-56. PubMed ID: 25132338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of piperazine ferulate on TGF-beta1-induced renal interstitial fibroblast activation].
    You GQ; Fu P; Xie XS; Liu F; Li J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):736-9, 762. PubMed ID: 19024302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone attenuates activation of human Tenon's fibroblasts induced by transforming growth factor-β1.
    Fan F; Li Y; Duan X; Zhao T; Pan D; Chen H
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1213-20. PubMed ID: 22215258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
    Suzuki H; Uchida K; Nitta K; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
    Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
    Hao GH; Niu XL; Gao DF; Wei J; Wang NP
    Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta.
    Kawai T; Masaki T; Doi S; Arakawa T; Yokoyama Y; Doi T; Kohno N; Yorioka N
    Lab Invest; 2009 Jan; 89(1):47-58. PubMed ID: 19002105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Connective tissue growth factor synergistically with transforming growth factor beta 1 to promote renal fibrosis].
    Yang M; Huang HC; Li JZ; Wang HY
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):569-73. PubMed ID: 15144592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.